Our prior research indicated that NAF enantiomers could serve as novel and effective regulators of UGT2B15, enhancing the elimination of DHT and promoting apoptosis in BPH-1 cells [30]. The gene discussed is UGT2B15; the disease is benign prostatic hyperplasia.